
Cameron A. Carter
Examiner (ID: 8026, Phone: (571)272-3290 , Office: P/3765 )
| Most Active Art Unit | 3765 |
| Art Unit(s) | 3732, 3765 |
| Total Applications | 273 |
| Issued Applications | 95 |
| Pending Applications | 3 |
| Abandoned Applications | 173 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18281719
[patent_doc_number] => 20230097191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Treatment of Hypercoagulopathy in Cushing's Syndrome by Administration of Glucocorticoid Receptor Modulators
[patent_app_type] => utility
[patent_app_number] => 17/983971
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/983971 | Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators | Nov 8, 2022 | Issued |
Array
(
[id] => 19701650
[patent_doc_number] => 12195662
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Phytol-based surfactants and methods therefor
[patent_app_type] => utility
[patent_app_number] => 17/970938
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4835
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970938 | Phytol-based surfactants and methods therefor | Oct 20, 2022 | Issued |
Array
(
[id] => 19473865
[patent_doc_number] => 12103941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Radiation-activatable platinum complex, its preparation and therapeutic use
[patent_app_type] => utility
[patent_app_number] => 18/045210
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 28
[patent_no_of_words] => 9547
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045210
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045210 | Radiation-activatable platinum complex, its preparation and therapeutic use | Oct 9, 2022 | Issued |
Array
(
[id] => 18283596
[patent_doc_number] => 20230099068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => TOPICAL ANTIMICROBIAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/955543
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17955543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/955543 | TOPICAL ANTIMICROBIAL FORMULATIONS | Sep 28, 2022 | Abandoned |
Array
(
[id] => 18299425
[patent_doc_number] => 20230109111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => NEW PYRIDO DIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM
[patent_app_type] => utility
[patent_app_number] => 17/934769
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934769 | NEW PYRIDO DIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM | Sep 22, 2022 | Abandoned |
Array
(
[id] => 18793847
[patent_doc_number] => 11827598
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-28
[patent_title] => Preparation method of tofacitinib citrate
[patent_app_type] => utility
[patent_app_number] => 17/940984
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4941
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940984 | Preparation method of tofacitinib citrate | Sep 7, 2022 | Issued |
Array
(
[id] => 19049222
[patent_doc_number] => 20240091191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => USES OF CORYLIN AND/OR NEOBAVAISOFLAVONE IN TREATING SYMPTOMS ASSOCIATED WITH SENESCENCE
[patent_app_type] => utility
[patent_app_number] => 17/902795
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/902795 | USES OF CORYLIN AND/OR NEOBAVAISOFLAVONE IN TREATING SYMPTOMS ASSOCIATED WITH SENESCENCE | Sep 1, 2022 | Abandoned |
Array
(
[id] => 18107997
[patent_doc_number] => 20230000877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => COMBINATION THERAPY FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/892651
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17892651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/892651 | COMBINATION THERAPY FOR TREATING CANCER | Aug 21, 2022 | Abandoned |
Array
(
[id] => 18192559
[patent_doc_number] => 20230046078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => METHODS OF USING SUBSTITUTED FLAVONES FOR TREATING BONE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/866008
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 295
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866008 | METHODS OF USING SUBSTITUTED FLAVONES FOR TREATING BONE DISORDERS | Jul 14, 2022 | Abandoned |
Array
(
[id] => 18150193
[patent_doc_number] => 20230024050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => Dermatological Compositions and Methods of Treatment against Cutaneous T-Cell Lymphoma
[patent_app_type] => utility
[patent_app_number] => 17/860599
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860599 | Dermatological Compositions and Methods of Treatment against Cutaneous T-Cell Lymphoma | Jul 7, 2022 | Abandoned |
Array
(
[id] => 18893655
[patent_doc_number] => 20240009140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 17/857970
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857970 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERTENSION | Jul 4, 2022 | Abandoned |
Array
(
[id] => 18148926
[patent_doc_number] => 20230022783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PREPARATION AND APPLICATION OF TRITERPENOIDS WITH EFFECT OF IMPROVING GLUCOSE AND LIPID METABOLISM DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/855823
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855823 | Preparation and application of triterpenoids with effect of improving glucose and lipid metabolism disorders | Jun 30, 2022 | Issued |
Array
(
[id] => 18184367
[patent_doc_number] => 20230045097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => MULTI-FUNCTIONAL NANOPARTICLE TARGETED TO BREAST CANCER, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/854685
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854685
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854685 | MULTI-FUNCTIONAL NANOPARTICLE TARGETED TO BREAST CANCER, PREPARATION METHOD AND USE THEREOF | Jun 29, 2022 | Abandoned |
Array
(
[id] => 18626588
[patent_doc_number] => 20230285380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => DUAL TREATMENT OF MIGRAINE
[patent_app_type] => utility
[patent_app_number] => 17/838171
[patent_app_country] => US
[patent_app_date] => 2022-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838171 | DUAL TREATMENT OF MIGRAINE | Jun 10, 2022 | Abandoned |
Array
(
[id] => 17864571
[patent_doc_number] => 20220287306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHOD FOR IMPROVING TURFGRASS ABIOTIC STRESS TOLERANCE
[patent_app_type] => utility
[patent_app_number] => 17/828526
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17828526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/828526 | METHOD FOR IMPROVING TURFGRASS ABIOTIC STRESS TOLERANCE | May 30, 2022 | Pending |
Array
(
[id] => 17828270
[patent_doc_number] => 20220265574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => METHODS OF USING CANNABIDIOL AND A STEROID
[patent_app_type] => utility
[patent_app_number] => 17/744996
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744996
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744996 | METHODS OF USING CANNABIDIOL AND A STEROID | May 15, 2022 | Pending |
Array
(
[id] => 19360785
[patent_doc_number] => 20240262819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST GLUCOSYLCERAMIDE SYNTHASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/559466
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559466
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559466 | NOVEL COMPOUNDS HAVING INHIBITORY ACTIVITY AGAINST GLUCOSYLCERAMIDE SYNTHASE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESSES FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | May 9, 2022 | Pending |
Array
(
[id] => 18284665
[patent_doc_number] => 20230100137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/733419
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733419
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/733419 | METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE | Apr 28, 2022 | Abandoned |
Array
(
[id] => 20343091
[patent_doc_number] => 12466813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => PRC1 inhibitors and methods of treatment therewith
[patent_app_type] => utility
[patent_app_number] => 17/732124
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 35273
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/732124 | PRC1 inhibitors and methods of treatment therewith | Apr 27, 2022 | Issued |
Array
(
[id] => 18281868
[patent_doc_number] => 20230097340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/730764
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 300
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730764 | METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE | Apr 26, 2022 | Abandoned |